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Hermansky–Pudlak syndrome (HPS) is an autosomal recessive disorder characterized by oculocutaneous albi-
nism, a bleeding disorder, and ceroid lipofuscinosis in the lungs and gut. HPS is genetically heterogeneous and the
most common variant, HPS type 1, is caused by mutations in HPS1 gene. The protein encoded by HPS1 is con-
sidered to facilitate the trafﬁcking of melanocyte-specific gene products into the premelanosome. We report the
ultrastructural ﬁndings in a melanocytic nevus seen in a 17-y-old Japanese female patient with HPS1 who is a
compound heterozygote of HPS1 mutations, including a novel mutation. Electron microscopy of a pinkish papule
corresponding to the melanocytic nevus revealed markedly aberrant, immature melanosomes, large membranous
structures, and giant melanosomes in the vicinity of trans-Golgi network, the characteristic abnormalities because
of protein trafﬁcking defects in HPS1. These ultrastructural features were far more clearly demonstrated in the
nevus cells than in the epidermal melanocytes. Thus, ultrastructural analysis of nevus cells may be an additional
diagnostic tool for HPS1 and could give us important clues to further understanding of the pathomechanisms of
HPS.
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Hermansky–Pudlak syndrome (HPS; MIM 203300) is a rare,
autosomal recessive disorder characterized by oculocuta-
neous albinism, bleeding diathesis, and lysosomal accu-
mulation of ceroid lipofuscin. HPS was first described by
Hermansky and Pudlak (1959). Mutations in seven genes,
HPS1–7 have been identified to cause HPS in humans (Oh
et al, 1996; Dell’Angelica et al, 1999; Anikster et al, 2001;
Suzuki et al, 2002; Li et al, 2003; Zhang et al, 2003) and
HPS1 is the most common causative gene.
Proteins encoded by HPS genes are thought to be in-
volved in trafficking of lysosome proteins and lysosome-
related organelles, and abnormalities of lysosomes and
other specific organelles, such as platelet dense granules,
lung lamellar bodies, and melanosomes, have been ob-
served during light and electron microscopic examination.
Melanocytes in HPS contain predominantly premature
melanosomes and abnormal, large membranous structures
including tubulovesicular structures because of these traf-
ficking defects (Witkop et al, 1973; Frenk and Lattion, 1982;
Boissy et al, 1998; Husain et al, 1998).
In this study, we demonstrated ultrastructural features of
the nevus cells from an HPS patient harboring one novel
and one recurrent HPS1 mutations. The present findings
seen in the nevus cells could provide us significant infor-
mation for the diagnosis of HPS.
Results
Clinical presentation The patient was a 17-y-old Japa-
nese female. She was the second child of non-consanguin-
eous, healthy parents. There was no family history of
genodermatosis including albinism. She had one unaffected
elder sister. She had presented with oculocutaneous albi-
nism since birth and had a history of easy bruising. No in-
fectious diathesis was noted. On physical examination, we
noted that her skin was extraordinarily pale for a Japanese
patient, and her hair was pale blonde (Fig 1a). Her eyes
were pale red-brown. Ophthalmologic examination revealed
mild horizontal nystagmus and slightly reduced visual acu-
ity. A round, pinkish papule, measuring 5 mm in diameter,
was seen on her neck (Fig 1b). The papule was resected
and processed for morphological observation. Laboratory
examination showed decreased platelet aggregation to col-
lagen. Chest computed tomography demonstrated no ev-
idence of interstitial pneumonitis. Gastrointestinal and colon
endoscopies revealed no abnormality and granulomatous
colitis was excluded.
HPS gene mutation analysis The mutation analysis for her
HPS1 gene revealed that the patient was a compound he-
terozygote for a novel mutation IVS6þ1G4A (Fig 2a) (se-
quence according to GenBank accession No. AF450133)
and a recurrent HPS1 mutation IVS5þ 5G4A (Fig 2b),
which has been reported in Japanese HPS patients (Oh
et al, 1998; Horikawa et al, 2000). We previously reported
Abbreviations: CHS, Chediak–Higashi syndrome; HPS, Herman-
sky–Pudlak syndrome
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that IVS5þ 5G4A is a pathologic mutation with an exper-
imental evidence, which results in the exon 5 skipping
(Suzuki et al, 2004). Then we investigated an aberrant splice
pattern caused by the IVS6þ 1G4A mutation with the RT-
PCR method using the patient RNA. The allele with the
IVS6þ 1G4A mutation was amplified with primers span-
ning around exons 5–7. This primer set would not
amplify the transcript derived from another allele with
IVS5þ 5G4A which defected exon 5 because of the exon
5 skipping. The result showed that, in the transcript, next GT
site within intron 6 (IVS6þ 44) was used for a splice donor
site, resulting in a frameshift in the mutant mRNA (Fig 2c).
Histological and ultrastructural ﬁndings of a pigmented
nevus in HPS Light microscopy of the skin sample from
the papule of the patient showed that cuboidal or oval cells
with round nuclei were clustered in the dermis (Fig 3a). A
small number of nevus cells contained melanin pigment
(Fig 3b). Electron microscopy revealed that melanocytes in the
epidermis contained mainly premature melanosomes in the
cytoplasm, although a few electron dense, mature melano-
somes were seen (Fig 4a). Most of the melanosomes were in
stage I or II, and stage IV melanosomes were rarely seen.
The nevus cells in the dermis contained abundant ves-
icles of a similar size to that of normal melanosomes (Fig
4b), ceroid-like structures and electron-dense pigment with-
in these vesicles (Fig 4c), whereas only a small number of
those vesicles were also observed in the epidermal me-
lanocytes (Fig 4a). In addition, remarkable, large electron-
dense structures, 0.7 mm in diameter were seen at the pe-
riphery of the trans-Golgi network (Fig 4d). These abnormal
structures, included large membranous structures, large
Figure 1
Clinical features of the Hermansky–Pudlak Syndrome 1 patient. (a)
The face of the patient. The skin is pale and the hair is bright gold in
color as a Japanese girl. Her eyes are pale red-brown (not shown). (b) A
pinkish papule, melanocytic nevus, 5 mm in diameter, was present on
her neck.
Figure 2
HPS gene mutations and altered spli-
cing in the patient. Direct DNA sequence
analysis of the splice donor sites in
IVS6 (a) and IVS5 (b) in the HPS1 gene.
In IVS6, þ 1G4A was detected and in
IVS5, þ 5G4A mutation was identified.
(c) A mutation of G to A at the first base of
IVS6 abolished the 50 splice site. RT-PCR
and DNA sequence analysis showed that
the corresponding mRNA was aberrantly
spliced, using a cryptic 50 splice site with-
in IVS6, which resulted in a frameshift.
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electron-dense structures, and immature vesicles were re-
markably abundant in the nevus cells compared with other
cells including epidermal melanocytes.
Electron microscopy showed that, in a control melanocy-
tic nevus of a healthy female, mature melanosomes were
scattered and partly aggregated presumably as autophagic
vacuoles in the cytoplasm (Fig 4e). Neither giant melano-
somes nor aberrant vesicles were observed.
Discussion
HPS comprises a group of heterozygous disorders that re-
sult from abnormal vesicle formation and protein trafficking.
At least, seven human HPS subtypes have been identified
(HPS1–7).
HPS1 gene was mapped 10q23 (Fukai et al, 1995;
Wildenberg et al, 1995). It has an open reading frame of
2103 bp, and is divided into 20 exons (Oh et al, 1996). To
date, about 20 gene mutations in HPS1 have been reported
(Hermos et al, 2002; Huizing and Gahl, 2002), and the most
common mutation in HPS1 is a 16 bp duplication in exon
15, frequently found in Puerto Rican pedigrees (Oh et al,
1996, 1998). The present patient was a compound hetero-
zygote for a novel mutation of HPS1, IVS6þ1G4A and a
previously known mutation, IVS5þ 5G4A (Oh et al, 1998;
Horikawa et al, 2000). Both mutations are splice donor site
mutations. Besides the present case, only one splice ac-
ceptor site mutation IVS172A4C has been reported as a
splice mutation in HSP1 (Oetting and King, 1999; Hermos
et al, 2002).
Abnormal melanosomes have been reported in HPS pa-
tients (Witkop et al, 1973; Frenk and Lattion, 1982; Boissy
et al, 1998; Husain et al, 1998) and in murine models of HPS
(Nguyen and Wei, 2004). HPS1 protein has been thought to
function in trafficking molecules to lysosome-related organ-
elles and to be closely related to the formation of lysosome-
related organelles. Especially in melanocytes, the HPS1
protein was thought to be involved in sorting melanosome-
specific molecules and in formation of early vesicles
(premelanosomes) from the trans-Golgi network (Huizing
and Gahl, 2002). Previous reports also revealed that
melanocytes in HPS patients had exclusively premature
melanosomes (Witkop et al, 1973; Frenk and Lattion, 1982;
Boissy et al, 1998; Husain et al, 1998). Because of the fact
that nevus cells frequently show high melanin producing
activity, we hypothesized that melanocytic nevus might
show exaggerated abnormalities compared with me-
lanocytes in the epidermis.
Our ultrastructural observation of nevus cells in the HPS
patient revealed abnormal vesicles, large membranous
structures, and large electron-dense structures, whereas
those structures were scarcely seen in epidermal me-
lanocytes of the patient. Many of those abnormal structures
retained small amount of pigmentation, elliptical shape, or
striations characteristic to melanosomes, and they were
thought to be aberrant melanosomes, although we could
not excluded the possibility that some of the vesicles were
of lysosomal origin. These include abnormal immature
melanosomes, large membranous structures, and remark-
able large electron-dense structures (giant melanosomes),
which were observed abundantly in the periphery to the
trans-Golgi network and were thought to be representing
trafficking defects, characteristic to HPS. We have utilized
genetic analysis and blood clotting assessment for the di-
agnosis of HPS, and it is true those tests are highly useful.
We think ultrastructural analysis of nevus cells can be used
as an additional diagnostic procedure.
Giant melanosomes have also been demonstrated in
melanocytes from non-Puerto Rican HPS patients (Frenk
and Lattion, 1982; Lattion et al, 1983; Schallreuter et al,
1993; Horikawa et al, 2000). Among the patients showing
giant melanosomes, mutations were detected only in two
patients and both patients had identical mutations,
IVS5þ 5G4A. Those abnormal melanosomes have never
been observed in Puerto Rican HPS patients. Horikawa et al
(2000) speculated that this distinction might be because of
the HPS1 gene mutation sites and nature of the defects.
Mutation site and/or the nature of IVS5þ5G4A lesion
might affect vesicle–vesicle fusion, which would result in the
Figure 3
Microscopic features of the pinkish melanocytic nevus on her
neck. (a) Abundant nevus cells are aggregated in the dermis (hem-
atoxylin and eosin, scale bar: 80 mm). (b) A few nevus cells contain
melanin pigment (arrows) (hematoxylin and eosin, scale bar: 30 mm).
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formation of large membranous structures and giant
melanosomes as observed in the nevus cells in our HPS
patient.
Interestingly, giant melanosomes are also seen in pa-
tients with Chediak–Higashi syndrome (CHS), a lysosomal
disorder that also presents as oculocutaneous albinism,
similar to HPS (Zelickson et al, 1967). CHS protein is con-
sidered to be a negative regulator of vesicle–vesicle fusion
and impaired CHS protein function that promotes formation
of large vesicles, such as giant melanosomes (Huizing et al,
2001; Marks and Seabra, 2001).
To our knowledge, this is the first report describing ul-
trastructural features of a nevus cell in an HPS patient. This
study revealed that characteristic abnormalities because of
protein trafficking defects, aberrant immature melano-
somes, large membranous structures, and remarkable large
electron-dense structures in the vicinity of the trans-Golgi
network, were more clearly demonstrated in the cells in the
melanocytic nevus than in other cell types including the
epidermal melanocytes. These characteristic ultrastructural
findings in nevus cells could provide important clues to fur-
ther understanding of the pathomechanism of HPS.
Materials and Methods
Mutation detection Using a genomic DNA purification kit (QIA-
GEN, Valencia, California), genomic DNA was isolated from pe-
ripheral blood of the patient. Her HPS1 gene was amplified from
her genomic DNA by PCR using the primers and PCR conditions
described previously (Bailin et al, 1997). The amplified fragments
were then screened for mutations by simultaneous analyses of
single-stranded conformation polymorphisms and heteroduplexes
method (Spritz et al, 1992). PCR products showing aberrant pat-
terns were reamplified and sequenced directly. For RT-PCR anal-
ysis RNA was extracted from mononuclear cells in the peripheral
blood. The primers for RT-PCR were EX5cf; 50-TGTGGACGGT-
CATCTTATCC-30 in exon 5 and EX7cr; 50-GGTGTTGACAGCCTG-
GATGA-30 in exon 7.
Ultrastructural observations A papule on the patient’s neck was
resected for morphological observation. In addition, a skin sample
of a control melanocytic nevus was obtained from a 29-y-old un-
related female. The pigmented lesion had been present on her
back for 10 y. Skin biopsy samples were fixed in 2% glutaralde-
hyde solution, post-fixed in 1% OsO4, dehydrated, and embedded
in Epon 812 (Perry et al, 1987). The samples were sectioned at
1 mm thickness for light microscopy and thin sectioned for electron
microscopy (70 nm thick). The histological sections were stained
by the method of Richardson et al (1960). The thin sections were
stained with uranyl acetate and lead citrate (Reynolds, 1963) and
examined in a transmission electron microscope.
The medical ethical committee of Hokkaido University ap-
proved all described studies. The study was conducted according
to Declaration of Helsinki Principles. Participants gave their written
informed consent.
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